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di-8-ANEPPSDipole potential is the potential difference within the membrane bilayer, which originates due to the
nonrandom arrangement of lipid dipoles and water molecules at the membrane interface. In this work, we
have explored the possible correlation between functional modulation of a G protein-coupled receptor (the
serotonin1A receptor) andmembrane dipole potential, under conditions of altered membrane sterol composi-
tion.We have previously shown that the ligand binding activity of the hippocampal serotonin1A receptor is re-
duced upon cholesterol depletion and could be restored upon replenishment with cholesterol. Interestingly,
when the replenishment was carried out with an immediate biosynthetic precursor of cholesterol (7-DHC),
differingwith cholesterol merely in a double bond, the ligand binding activity of the receptor was not restored.
In order to understand the mechanistic framework of receptor–cholesterol interaction, we carried out dipole
potential measurements of hippocampal membranes under these conditions, by the dual wavelength
ratiometric approach using an electrochromic probe (di-8-ANEPPS). We show here that dipole potential of
hippocampalmembranes is reduced upon progressive depletion of cholesterol and is restored upon replenish-
ment with cholesterol, but not with 7-DHC. Our results show that the recovery of ligand binding activity of the
serotonin1A receptor upon replenishmentwith cholesterol (but not with 7-DHC) could be related to the differ-
ential ability of these closely related sterols to modulate membrane dipole potential. We conclude that subtle
changes in membrane dipole potential could be crucial in understanding the complex interplay between
membrane lipids and proteins in the cellular milieu.
© 2012 Elsevier B.V. All rights reserved.1. Introduction
Dipole potential is an internal potential of biological membranes
and is generated due to the nonrandom orientation of electric dipoles
of lipid and water molecules at the membrane interface [1–4]. The
magnitude of dipole potential has been estimated to be 200–1000 mV,
depending on membrane composition and this results in enormous
electric ﬁeld strength in the range of 108–109 Vm−1 within the mem-
brane [1,2]. Dipole potential has been implicated to inﬂuence the func-
tion of membrane proteins and peptides such as Na+/K+-ATPase [5]
and the ion channel gramicidin [6,7]. Modulation of dipole potential
has been reported to affect the membrane insertion and folding ofH-DPAT, 8-hydroxy-2(di-N-
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rights reserved.amphiphilic peptides such as p25 (the signal sequence of subunit IV of
cytochrome c oxidase) [8], and simian immunodeﬁciency viral fusion
peptide [9]. Importantly, it has been proposed that the dipole potential
may play a crucial role in the structure and function of proteins associ-
ated with cholesterol-rich domains in the membrane [4]. Interestingly,
cholesterol has been shown to increase membrane dipole potential
[10,11].
Cholesterol is an essential component of eukaryotic membranes
and plays a crucial role in membrane organization, dynamics, function
and sorting [12,13]. Cholesterol is the end product of a long,multi-step
and exceedingly ﬁne-tuned sterol biosynthetic pathway involving
more than 20 enzymes. According to the “Bloch hypothesis”, proposed
by Konrad Bloch, the sterol biosynthetic pathway parallels sterol evo-
lution [14]. It essentially means that cholesterol is selected over a very
long time scale of natural evolution for its ability to optimize certain
physical properties of eukaryotic cell membranes with regard to bio-
logical functions. Cholesterol precursors should therefore have prop-
erties that gradually support cellular function of higher organisms
as they progress along the pathway toward cholesterol. Defects in
cholesterol biosynthetic pathway have been identiﬁed with several
inherited metabolic disorders [15]. For example, the Smith–Lemli–
Opitz Syndrome (SLOS), a congenital and developmental malfor-
mation syndrome, is clinically diagnosed by reduced plasma levels
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(7-DHC) [15]. 7-DHC is an immediate biosynthetic precursor of cho-
lesterol in the Kandutsch–Russell pathway [16]. It differs with cho-
lesterol only in a double bond at the 7th position in the sterol ring
(see Fig. 1).
The G protein-coupled receptor (GPCR) superfamily is the largest
andmost diverse protein family in mammals, involved in signal trans-
duction acrossmembranes [17,18]. There aremore than 800members
of the GPCR superfamily and typically they are seven transmembrane
domain proteins. Due to their role in regulatingmultiple physiological
processes, GPCRs have emerged as major drug targets in all clinical
areas [19]. It is estimated that ~50% of currently prescribed drugs act
as either agonists or antagonists of GPCRs [20]. The serotonin1A recep-
tor is an important neurotransmitter receptor of the GPCR family and
is implicated in the generation and modulation of various cognitive,
behavioral and developmental functions [21–23]. Agonists [24] and
antagonists [25] of the serotonin1A receptor represent major classes
of molecules with potential therapeutic applications in anxiety- or
stress-related disorders.
Cholesterol plays an important role in the function and organiza-
tion of membrane proteins and receptors [26–30]. The exact mecha-
nism of the interaction of cholesterol with membrane proteins and
receptors is not clear. It has been proposed that such effects of choles-
terol on integral membrane proteins could occur either through
speciﬁc molecular interaction, or due to alterations in membrane
physical properties, or by a combination of both [31,32]. Earlier work
from our laboratory comprehensively demonstrated the requirement
of membrane cholesterol in the organization, dynamics and function
of the serotonin1A receptor ([33–36]; recently reviewed in [28,30]).
We showed that the function of the serotonin1A receptor is impaired
in SLOS-like condition, i.e., in presence of 7-DHC [34,37]. This implies
that the interaction between cholesterol and the serotonin1A receptor
is considerably stringent since 7-DHC, an immediate biosynthetic pre-
cursor of cholesterol differing with cholesterol in a double bond, was
not able to maintain receptor function.
With an overall objective of broadening the mechanistic frame-
work of receptor–cholesterol interaction, we have explored here the
correlation between functional changes in the serotonin1A receptor
induced by alterations in sterol composition and membrane dipole
potential. We show here that dipole potential of hippocampal mem-
branes is reduced upon progressive depletion of cholesterol and is re-
stored upon cholesterol replenishment. Interestingly, replenishment
with 7-DHC could not restore dipole potential in hippocampal mem-
branes, thereby providing novel insight into the loss of receptor activ-
ity under these conditions.
2. Materials and methods
2.1. Materials
Cholesterol, 7-DHC, MβCD, DMPC, EDTA, EGTA, MgCl2, MnCl2,
Na2HPO4, iodoacetamide, PMSF, sucrose, sodium azide and Tris wereHOHO
Cholesterol7-Dehydrocholesterol
Fig. 1. Chemical structures of 7-dehydrocholesterol (7-DHC) and cholesterol. 7-DHC is
the immediate biosynthetic precursor of cholesterol in the Kandutsch–Russell pathway
[16], one of the two routes of cholesterol biosynthesis. 7-DHC differs with cholesterol
only in a double bond at the 7th position in the sterol ring, as highlighted in its structure.obtained from Sigma Chemical Co. (St. Louis, MO). BCA reagent for pro-
tein estimation was from Pierce (Rockford, IL). DPPC was from Avanti
Polar Lipids (Alabaster, AL). Di-8-ANEPPS was purchased fromMolecu-
lar Probes (Eugene, OR). Pre-coated silica gel 60 thin layer chromatogra-
phy plateswere fromMerck (Darmstadt, Germany). The purity of lipids
was checked by thin layer chromatography on silica gel precoated
plates (Merck) in chloroform/methanol/water (65:35:5, v/v/v) and
was found to give only one spot with a phosphate-sensitive spray and
on subsequent charring [38]. All other chemicals and solvents used
were of the highest purity available. Water was puriﬁed through a
Millipore (Bedford, MA) Milli-Q system and used throughout. Fresh
bovine brains were obtained from a local slaughterhouse within
10 min of death and the hippocampal region was carefully dissected
out. The hippocampi were immediately ﬂash frozen in liquid nitrogen
and stored at−70 °C until further use.
2.2. Methods
2.2.1. Preparation of native hippocampal membranes
Native hippocampal membranes were prepared as described ear-
lier [33]. Native membranes were suspended in a minimum volume
of 50 mM Tris, pH 7.4 buffer, homogenized using a hand-held Dounce
homogenizer, ﬂash frozen in liquid nitrogen and stored at −70 °C.
Protein concentration was determined using the BCA reagent with
bovine serum albumin as a standard [39].
2.2.2. Cholesterol depletion of native membranes
Native hippocampal membranes were depleted of cholesterol using
MβCD as described previously [33,37]. Brieﬂy, membranes with a total
protein concentration of ~2 mg/ml were treated with varying concen-
trations (10–40 mM) of MβCD in 50 mM Tris, pH 7.4 buffer at 25 °C
in a temperature controlled water bath with constant shaking for 1 h.
Membranes were spun down at 50,000 ×g for 10 min, washed with
the Tris buffer and resuspended in the same buffer. Membrane choles-
terol was estimated using the Amplex Red cholesterol assay kit [40].
2.2.3. 7-DHC and cholesterol replenishment of cholesterol-depleted
membranes
Cholesterol-depleted hippocampal membranes were replenished
with 7-DHC or cholesterol using 7-DHC–MβCD or cholesterol–MβCD
complex as described earlier [37]. 7-DHC–MβCD or cholesterol–MβCD
complex was prepared by dissolving the required amounts of sterols
and MβCD in a ratio of 1:10 (mol/mol) in 50 mM Tris, pH 7.4 buffer
by constant shaking at 25 °C. Stock solutions (typically 2 mM 7-DHC
or cholesterol: 20 mM MβCD) of this complex were freshly prepared
before each experiment. Sterol (7-DHC or cholesterol) replenishment
was carried out at a protein concentration of 2 mg/ml by incubating
the cholesterol-depleted membranes with 1 mM sterol:10 mM MβCD
complex for 1 h in 50 mM Tris, pH 7.4 buffer at 25 °C under constant
shaking. Membranes were spun down at 50,000 ×g for 10 min at 4 °C,
washed with Tris buffer and resuspended in the same buffer.
2.2.4. Estimation of 7-DHC and cholesterol by thin layer chromatography
Lipid extraction from native, cholesterol-depleted, and sterol
(cholesterol or 7-DHC)- replenished membranes was carried out
according to Bligh and Dyer [41]. Lipid extracts were dried under a
stream of nitrogen at 45 °C. The dried extracts were dissolved in a
mixture of chloroform/methanol (1:1, v/v). 7-DHC and cholesterol
were resolved by thin layer chromatography. TLC plates were impreg-
nated with a 3% (w/v) silver nitrate solution in methanol, allowed to
dry brieﬂy and activated at 120 °C for 15 min. Cholesterol and 7-DHC
were separated from total lipid extracts using n-heptane/ethyl ace-
tate (2:1, v/v) as the solvent system [42]. The separated lipids were
visualized on the TLC plate by charring with a solution containing cu-
pric sulfate (10%, w/v) and phosphoric acid (8%, v/v) at 150 °C for
~5 min. 7-DHC and cholesterol bands were identiﬁed with the help
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were analyzed using the Adobe Photoshop software version 5.0
(Adobe Systems, San Jose, CA). Intensities of sterols from all samples
on TLC plates were normalized to intensity of the cholesterol band
obtained from the native membrane.
2.2.5. Estimation of phospholipids
Concentration of lipid phosphatewas determined subsequent to total
digestion by perchloric acid [43] using Na2HPO4 as standard. DMPC was
used as an internal standard to assess lipid digestion. Samples without
perchloric acid digestion produced negligible readings. The phospholipid
content of native membranes is typically ~960 nmol/mg of total protein
[44].
2.2.6. Sample preparation
Di-8-ANEPPS from amethanolic stock solution was added to hippo-
campal membranes containing 200 nmol total phospholipid in 1.5 ml
of 50 mM Tris, pH 7.4 buffer. The amount of di-8-ANEPPS added was
such that the ﬁnal probe concentration was ~1 mol% with respect to
total phospholipid content. The concentration of the stock solution of
di-8-ANEPPS in methanol was estimated from its molar absorption co-
efﬁcient of 37,000 M−1 cm−1 at 498 nm [45]. The ﬁnal di-8-ANEPPS
concentrationwas 1.3 μM in all cases andmethanol content was always
low (0.33%, v/v). This ensures optimal ﬂuorescence intensity with
negligible membrane perturbation. Di-8-ANEPPS probe was added
to membranes while being vortexed for 1 min at room temperature
(~23 °C).
For experiments with model membranes, large unilamellar vesi-
cles (LUVs) of 100 nm diameter of DPPC containing increasing con-
centrations (0–40 mol%) of cholesterol or 7-DHC were prepared. All
samples contained 1 mol% di-8-ANEPPS. For this, 640 nmol of total
lipid (DPPC and sterol) and 6.4 nmol of di-8-ANEPPS were mixed
well and dried under a stream of nitrogen while being warmed gently
(~35 °C). After further drying under a high vacuum for at least 3 h,
the lipid mixture was hydrated (swelled) by addition of 1.5 ml of
30 mM Tris, 1 mM EDTA, 150 mM sodium chloride, pH 7.4 buffer,
and each sample was vortexed for 3 min to uniformly disperse the
lipids and form homogeneous multilamellar vesicles. The buffer was
always maintained at a temperature (~60 °C) well above the phase
transition temperature of DPPC. LUVs of 100 nm diameter were
prepared by the extrusion technique using an Avestin Liposofast Ex-
truder (Ottawa, Ontario, Canada) as previously described [46]. Brieﬂy,
the multilamellar vesicles were freeze–thawed ﬁve times using liquid
nitrogen to ensure solute equilibration between trapped and bulk
solutions and then extruded through polycarbonate ﬁlters (pore
diameter of 100 nm) mounted in an extruder ﬁtted with Hamilton
syringes (Hamilton Company, Reno, NV). The samples were subjected
to 11 passes through the polycarbonate ﬁlters to give the ﬁnal LUV
suspension. Background samples were prepared in the same way ex-
cept that di-8-ANEPPS was not added to them. The optical density of
the samples measured at 420 and 520 nm were less than 0.15 in all
cases, which rules out any possibility of scattering artifacts. Samples
were incubated in dark for 12 h at room temperature (~23 °C) for
equilibration before measuring ﬂuorescence. All experiments were
done with multiple sets of samples at room temperature (~23 °C).
2.2.7. Membrane dipole potential measurement
Membrane dipole potential measurements were carried out by
dual wavelength ratiometric approach using voltage sensitive ﬂuores-
cence probe di-8-ANEPPS [5,10,11,47,48]. Steady state ﬂuorescence
measurements were performed with a Hitachi F-4010 spectroﬂuo-
rometer using 1 cm path length quartz cuvettes at room temperature
(~23 °C). Excitation and emission slits with a nominal bandpass of
5 nmwere used for all measurements. Background intensities of sam-
ples were subtracted from each sample to cancel any contribution due
to the solvent Raman peak and other scattering artifacts. Steady stateﬂuorescence intensities were recorded at two excitation wavelengths
(420 and 520 nm). Emission wavelength was ﬁxed at 670 nm. The
ﬂuorescence ratio (R), deﬁned as the ratio of ﬂuorescence intensities
at an excitation wavelength of 420 nm to that at 520 nm (emission
at 670 nm in both cases) was calculated [10]. The choice of the emis-
sion wavelength (670 nm) at the red edge of the ﬂuorescence spec-
trum has previously been shown to rule out membrane ﬂuidity
effects [47]. Dipole potential (ψd) in mV was calculated from R using
the linear relationship [5,10]:
ψd ¼ Rþ 0:3ð Þ= 4:3 10−3
 
ð1Þ
R values remained invariant after dilution of membrane samples,
indicating the absence of any scattering artifacts [49].
2.2.8. Statistical analysis
Signiﬁcance levels were estimated using Student's two-tailed un-
paired t-test using Graphpad Prism software version 4.0 (San Diego,
CA).
3. Results and discussion
3.1. Effect of cholesterol depletion on the dipole potential of hippocampal
membranes
Membrane cholesterol content can be modulated using MβCD.
MβCD is a water-soluble cyclic polysaccharide with a nonpolar cen-
tral cavity. It is known to efﬁciently extract cholesterol from cellular
membranes [27,50,51] and has been used previously to extract cho-
lesterol from hippocampal membranes [33,37]. Cholesterol content
of hippocampal membranes shows progressive reduction upon treat-
ment with increasing concentrations of MβCD (see Fig. 2a). The cho-
lesterol content is reduced to ~78% of the initial (control) level when
native membranes were treated with 10 mM MβCD. The extent of
cholesterol depletion was maximal when 40 mM MβCD was used.
Cholesterol was reduced to ~17% of the control under these condi-
tions (see Fig. 2a). Importantly, total phospholipid content remained
unaltered upon MβCD treatment (not shown), conﬁrming the selec-
tive extraction of cholesterol by MβCD under these conditions.
Dipole potential of hippocampal membranes was monitored utiliz-
ing the dual wavelength ratiometric approach with the electrochromic
probe di-8-ANEPPS. This method for the measurement of dipole poten-
tial has previously been used in a number of studies [10,11,47,48]. We
recently showed, using the parallax method [52], that the ﬂuorescent
styrylpyridinium group in di-8-ANEPPS is localized at the membrane
interface, at a distance of ~12 Å from the center of the bilayer [11].
The ﬂuorescence ratio (R) of the potential-sensitive styrylpyridinium
probe, di-8-ANEPPS, is sensitive to any change in the dipolar ﬁeld at
the membrane interface where the probe is localized. This is believed
to be due to electrochromic mechanism [45]. According to this mecha-
nism, the spectral shift displayed by a charge transfer ﬂuorescent
probe such as di-8-ANEPPS is related to the electric ﬁeld strength. It
should be mentioned that the ﬂuorescence ratio (R) of di-8-ANEPPS
has been shown to be sensitive to only dipole potential and is indepen-
dent of speciﬁc molecular interactions [48,53]. Fig. 2b shows the dipole
potential of hippocampal membranes with increasing cholesterol de-
pletion. The ﬁgure shows that the dipole potential of native hippocam-
pal membranes is ~287 mV. The membrane dipole potential displays
progressive reduction with increasing cholesterol depletion (i.e., de-
creasing membrane cholesterol content, see Fig. 2a) and attains a
value of ~227 mV when 40 mM MβCD was used (corresponding to
membrane cholesterol content ~17% of control value). This is in agree-
ment with previous results in which it was shown that membrane
dipole potential increases with increasing cholesterol content [10,11].
Fig. 2c shows a plot of membrane dipole potential vs. cholesterol
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Fig. 2. Effect of membrane cholesterol content on dipole potential of hippocampal
membranes. (a) Cholesterol content in hippocampal membranes upon treatment
with increasing concentrations of methyl-β-cyclodextrin (MβCD). (b) Dipole potential
of hippocampal membranes upon cholesterol depletion with increasing concentrations
of MβCD. (c) Correlation between dipole potential and cholesterol content in hippo-
campal membranes. Data plotted are from panels (a) and (b). Linear regression analy-
sis gave a correlation coefﬁcient, r ~0.99. Measurements were carried out at room
temperature (~23 °C). Data represent means±S.E. of at least three independent mea-
surements. It should be mentioned here that the error bars reﬂect errors in the mea-
surement of R, and not dipole potential (also applicable to Figs. 4, 5 and 6). This is
because the errors in dipole potential values include signiﬁcant contributions from
errors in the slope and intercept of the calibration curve on which Eq. (1) is based
[5]. Since R can be measured precisely, this method allows to compare dipole potential
values at different conditions, although the accurate determination of dipole potential
is difﬁcult. See Materials and methods for other details.
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sent means±S.E. of ﬁve independent experiments. (b) Speciﬁc [3H]8-OH-DPAT binding
to serotonin1A receptors in hippocampal membranes replenished with cholesterol and
7-DHC. Values for speciﬁc [3H]8-OH-DPAT binding under these conditions are from
[37]. See Materials and methods for other details.
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cholesterol content yielded a positive correlation of ~0.99. Such a strong
correlation between dipole potential and cholesterol content could
have functional implications measured in terms of receptor activity
(see later).
3.2. Effect of cholesterol and its immediate biosynthetic precursor on
receptor activity and dipole potential in hippocampal membranes
Hippocampal membranes are isolated from the hippocampal region
of the brain. They are neuronal in origin and have been established as arich source of GPCRs such as the serotonin1A receptor. Although the
membrane lipid composition of bovine hippocampus is not known,
the phospholipid composition of rat hippocampus has earlier been
reported [54–56]. Analysis of the phospholipid composition of the rat
hippocampus shows phosphatidylethanolamine, phosphatidylcholine,
and phosphatidylserine as the predominant headgroups, while the
fatty acid composition shows enrichment with 16:0, 18:0, 18:1, 18:2,
20:4, and 22:6 fatty acids. In addition, plasmalogens have been reported
in rat hippocampus. Hippocampal membranes are rich in protein and
cholesterol [44]. Previous work from our laboratory has established
native hippocampal membranes as a convenient natural source for
exploring the interaction of the serotonin1A receptor, an important
member of the GPCR family, with membrane lipids [33,57].
We have previously demonstrated the requirement of membrane
cholesterol in modulating ligand binding function of the hippocampal
serotonin1A receptor [33,37,58–61]. The effect of cholesterol and
its immediate biosynthetic precursor 7-DHC on the ligand binding
activity of the hippocampal serotonin1A receptor is shown in Fig. 3.
Fig. 3a shows the extents of replenishment of cholesterol and 7-DHC
into cholesterol-depleted hippocampal membranes replenished with
MβCD-sterol complex. Treatment of membranes with 40 mM MβCD
resulted in ~61% reduction in the cholesterol content (Fig. 3a). This
is accompanied by a corresponding reduction (~56%) in the speciﬁc
[3H]8-OH-DPAT binding (see Fig. 3b). Replenishment with cholesterol–
MβCD complex resulted in recovery of speciﬁc [3H]8-OH-DPAT binding
to ~65% of native membranes (Fig. 3b) when ~86% of the cholesterol
could be replenished (Fig. 3a). We have previously reported by satura-
tion binding analysis that the binding of the agonist [3H]8-OH-DPAT to
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Fig. 5. Effect of cholesterol and 7-DHC on dipole potential in model membranes. Dipole
potential of (a) POPC and (b) DPPC membranes were monitored with increasing
concentrations of cholesterol (crisscrossed bar) and 7-DHC (hatched bar). Values for
POPC (panel a) are from [11]. Data represent means±S.E. of at least three independent
measurements. The ratio of di-8-ANEPPS to total lipid was 1:100 (mol/mol) and total
lipid concentration was 0.43 mM. Measurements were carried out at room tempera-
ture (~23 °C). See Materials and methods for other details.
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tion constant (Kd) of ~0.4 nM and maximum binding sites (Bmax) of
~125 fmol/mg. The reduction in speciﬁc agonist binding, upon choles-
terol depletion using 40 mMMβCD, could be attributed to a reduction
in the number of total binding sites with a marginal reduction in the
afﬁnity of ligand binding (Bmax ~90 fmol/mg and Kd ~0.5 nM in case
of cholesterol-depleted membranes) [33].
In order to monitor whether replenishment with 7-DHC could re-
store the speciﬁc [3H]8-OH-DPAT binding, cholesterol-depletedmem-
branes were replenished with 7-DHC using 7-DHC–MβCD complex.
Interestingly, the speciﬁc agonist binding could not be restored upon
replenishment with 7-DHC (Fig. 3b) in spite of the fact that the extent
of loading of 7-DHC was higher than what was obtained with choles-
terol replenishment (Fig. 3a). This is attributed to the inability of
7-DHC in restoring the speciﬁc agonist binding activity of the hippo-
campal serotonin1A receptor [37].
With an overall goal of correlating these sterol-dependent func-
tional changes with membrane properties, we measured dipole
potential of hippocampal membranes under these conditions. Fig. 4
shows that dipole potential of native hippocampal membranes is
~287 mV and is reduced to ~227 mV upon cholesterol depletion with
40 mMMβCD. Interestingly, cholesterol replenishment into hippocam-
pal membranes resulted in an increase of dipole potential to ~254 mV
with a concomitant recovery of speciﬁc agonist binding (see Fig. 3b).
In contrast to this, the increase in dipole potential of hippocampalmem-
branes upon replenishmentwith 7-DHC is not signiﬁcant andwas found
to be ~232 mV. These results show that replenishmentwith 7-DHCdoes
not restore dipole potential in hippocampalmembranes. This is in agree-
ment with our recent results that the ability of a sterol to modulate
membrane dipole potential could vary considerably depending on sterol
structure. Even a subtle difference such as a double bond (as is the case
with cholesterol and 7-DHC) in the sterol structure can have drastic
effect on the ability of the sterol to inﬂuencemembrane dipole potential
[11].
3.3. Effect of cholesterol and its immediate biosynthetic precursor on
dipole potential in gel and ﬂuid phase membranes
Natural membranes such as the hippocampal membrane are char-
acterized by complex composition and co-existing phases [62,63]. In
order to explore the role of membrane phase on the sterol-induced
modulation of membrane dipole potential, we chose to examine the
effect of cholesterol and 7-DHC on dipole potential in representative
ﬂuid (liquid-disordered), and gel (ordered) phase membranes. The
effect of these sterols on membrane dipole potential in ﬂuid phase
1-palmitoyl-2-oleoyl-sn-glycero-3-phosphocholine (POPC) membranes
has recently been reported [11] and is shown in Fig. 5a. The ﬁgure280
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Fig. 4. Effect of 7-DHC and cholesterol replenishment on dipole potential in hippocam-
pal membranes. All other conditions are as in Fig. 3. Values represent means±S.E. from
ﬁve independent experiments (* indicates signiﬁcant (p=0.0001) difference in dipole
potential corresponding to cholesterol-depleted and replenished hippocampal mem-
branes). See Materials and methods for other details.shows that the dipole potential of POPC membranes in the ﬂuid state
exhibits a progressive increase with increase in cholesterol concentra-
tion. This results in an increase of dipole potential from ~363 mV
(in absence of sterol) to ~580 mV in presence of 40 mol% cholesterol.
The corresponding change in dipole potential with 7-DHC was rather
modest, resulting in a membrane dipole potential of ~430 mV in pres-
ence of 40 mol% 7-DHC (this amounts to an increase of ~18% in contrast
to ~60% increase in case of cholesterol). The dipole potential of gel
phase DPPC membranes in absence of sterols was estimated to be
~334 mV (see Fig. 5b). Interestingly, the effect of cholesterol on mem-
brane dipole potential in the gel phase appears to bemore pronounced,
possibly due to less involvement of water dipoles (since water penetra-
tion is less in the gel phase due to tighter packing of lipids). The dipole
potential of DPPC membranes displays a concentration-dependent
increase with increasing cholesterol content and reaches a value of
~862 mV (~158% increase) when the cholesterol concentration was
30 mol%. Upon further increase in cholesterol concentration, a small re-
duction in dipole potential is observed. In case of 7-DHC, themembrane
dipole potential for DPPC membranes shows a modest increase up to
30 mol%, followed by a small reduction. Again, the increase in dipole
potential with increasing 7-DHC is rather less (~27%) compared to the
corresponding value for cholesterol (~158%, see above). An important
message from these results is that the effect of 7-DHC on themembrane
dipole potential is much less than that of cholesterol, independent of
the phase state of the membrane.
As stated earlier, our overall objective of extending dipole poten-
tial measurements to complex natural membranes such as the hippo-
campal membrane and its sterol content was to explore the role of
dipole potential in the mechanism of receptor–cholesterol interaction
and its functional correlates. We have previously shown that the in-
terfacial dielectric constant of hippocampal membranes increases
upon cholesterol depletion [64]. The reduction in dipole potential in
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Fig. 6. Inﬂuence of dipole potential on speciﬁc [3H]8-OH-DPAT binding to serotonin1A
receptors in hippocampal membranes. Speciﬁc [3H]8-OH-DPAT binding to serotonin1A
receptors (values from [33]) and corresponding values of dipole potential in hippocam-
pal membranes (from Fig. 2b) are shown. See Materials and methods for other details.
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uted in part to this increase in dielectric constant, since an increase
in dielectric constant would reduce dipole potential [2,10,11]. Fig. 6
shows the relevance of membrane dipole potential in the context of
receptor activity, as measured by speciﬁc [3H]8-OH-DPAT binding.
The apparent correlation observed between membrane dipole poten-
tial change and receptor activity under conditions of cholesterol de-
pletion is indeed encouraging.
In summary, we show here that the recovery of ligand binding
activity of the serotonin1A receptor upon replenishment with choles-
terol but not with 7-DHC could be related to the differential ability of
these closely related sterols to modulate membrane dipole potential.
A lower value of membrane dipole potential in presence of 7-DHC can
possibly be attributed to factors such as lower dipole moment of
7-DHC (1.42 D) relative to cholesterol (1.87 D) due to possible short-
ening of bond length, and difference in tilt angle in the membrane
[11]. This could be further due to the differential ability of cholesterol
and 7-DHC to polarize water molecules at the membrane interface
[10,65].
In the context of hippocampal membranes, which are of neuronal
origin, cholesterol represents an important lipid since it is known to
regulate the function of neuronal receptors [27,28,66], thereby affect-
ing neurotransmission and giving rise to mood and anxiety disorders
[67]. In a broader perspective, our results are signiﬁcant in understand-
ing the complex organization of neuronal membranes, and could have
functional implications in neuronal diseases such as the Smith–Lemli–
Opitz syndrome [15,34] characterized by low cholesterol (and high
7-DHC) condition due to defective cholesterol biosynthesis.
As mentioned earlier, membrane dipole potential has been
reported to inﬂuence the function of membrane proteins and peptides
such as Na+/K+-ATPase [5], the ion channel gramicidin [6,7], and the
membrane insertion and folding of the amphiphilic peptides such as
p25 [8], and the simian immunodeﬁciency viral fusion peptide [9].
Based on our present results, we envisage that in the complex inter-
play between membrane lipids and proteins that manifests in func-
tional changes of membrane proteins and receptors, consideration of
membrane dipole potential could turn out to be a sensitive parameter.
For example, the inhibition of activity of membrane proteins such as
Na+/K+-ATPase by ether lipids [68] could be due to larger dipole po-
tential for ester lipids than ether lipids [69].
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